Industry and Geographic Information

3 Months Ended

Mar. 31, 2020

Industry And Geographic Information [Abstract]

Industry and Geographic Information

Industry and Geographic Information

The Company operates in one reportable segment. Sales to customers outside the U.S. represented $41.2 million (24%) and $41.5 million (28%) of total revenue for the three months ended March 31, 2020 and 2019, respectively. As of March 31, 2020 and December 31, 2019, accounts receivable due from foreign customers were $24.1 million and $23.0 million, respectively.

The Company had sales to individual customers in excess of 10% of total revenues, as follows:

	Three Months Ended March 31,
	2020		2019
Customer:
A	21	%	17	%
B	19	%	17	%
C	10	%	7	%
D	10	%	13	%
Total:	60	%	54	%

As of March 31, 2020 and December 31, 2019, accounts receivable from customers with balances due in excess of 10% of total accounts receivable totaled $73.9 million and $67.4 million, respectively.

Consolidated total revenues by product category for the three months ended March 31, 2020 and 2019 were as follows (in thousands):

	Three Months Ended March 31,
	2020		2019
Rapid Immunoassay	$	95,930	$	62,494
Cardiometabolic Immunoassay	53,901		65,872
Specialized Diagnostic Solutions	16,459		13,854
Molecular Diagnostic Solutions	8,363		5,748
Total revenues	$	174,653	$	147,968